Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Abstract

The fact that a higher percentage CD133+ cells were strongly associated with a poorer prognosis in patients with locally advanced colon cancer implicated that CD133+ cancer cells contribute to the tumor progression, and the overpopulation hypothesis of cancer stem cell seems reasonable.